While all eyes are on the reverse split, Aurora Cannabis (ACB) investors should be more focused on FQ3 cost controls. The Canadian cannabis company has long had the ability to
While all eyes are on the reverse split, Aurora Cannabis (ACB) investors should be more focused on FQ3 cost controls. The Canadian cannabis company has long had the ability to
COVID-19 vaccine development across the globe is charging ahead with over 120 possible vaccines in progress. Healthcare companies of all sizes have thrown the proverbial hat into the lab, knowing
Over half the companies on the S&P 500 have delivered first quarter reports, and the print, so far, isn’t pretty. According to FactSet, blended earnings have declined by 13.7%, and
Over the past 5 years, with significant shareholder dilution along the way, Seanergy Maritime (SHIP) stock has declined by an incredible 99.70%. As investment sage, Warren Buffet famously said, the
It’s no secret, a large number of high-profile companies have taken a serious beating since the pandemic’s onset. Possibly none more well-known than Disney (DIS). COVID-19 has necessitated theme park
Investors are still uncertain just where the stock market is headed. Essentially, there are two competing opinions right now. One says that we’re just in a bear market rally, and
Does history repeat? Many of us, no doubt, remember the crash of the doc.com bubble back in 2000, and at least one analyst sees that pattern repeating before our eyes.
What is it that you look for in a biotech stock? Is it a good price-to-earnings ratio? Because at more than $53 per share, and trailing-12-month profits of negative $1.50
AbbVie’s (ABBV) acquisition of Allergan has entered the final stretch, after the FTC (federal trading commission) gave its consent for the deal to go ahead. With approval from the Irish
Even during global crises, there will always be winners. With a pandemic ravishing the global economy worldwide, Nvidia (NVDA) has managed to sail through the crisis relatively unscathed. Investors have